Don’t Undertreat Metastatic Prostate Cancer! Part 2
Roadblocks to Combination Therapy, and Paving the Way for Success As we discussed in Part 1, the year 2015 was a milestone in treatment of early metastasis (metastatic hormone-sensitive prostate cancer, or mHSPC). For the first time, the CHAARTED study showed that men with mHSPC who began ADT (androgen deprivation therapy, which shuts down […]